Matthias A Clauss Selected Research

Matthias A Clauss Research Topics

4	Inflammation (Inflammations) 01/2022 - 02/2008
2	Neointima 02/2008 - 04/2004
1	Hypoxia (Hypoxemia) 01/2022
1	HIV Infections (HIV Infection) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2021
1	Vascular Diseases (Vascular Disease) 06/2021
1	Emphysema 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Lung Injury 01/2019
1	Hyperglycemia 11/2018
1	Choroidal Neovascularization 01/2009
1	Wounds and Injuries (Trauma) 01/2009
1	Pathologic Neovascularization 01/2009
1	Vascular System Injuries 02/2008

3	CytokinesIBA 01/2022 - 02/2008
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2009
2	member 1 small inducible cytokine subfamily EIBA 01/2022 - 02/2008
2	Pentoxifylline (Trental)FDA LinkGeneric 01/2016 - 01/2013
2	Sirolimus (Rapamycin)FDA Link 02/2008 - 04/2004
1	Semaxinib (SU5416)IBA 01/2022
1	Illicit Drugs (Recreational Drugs)IBA 06/2021
1	SmokeIBA 01/2019
1	AntibodiesIBA 01/2019
1	Neutralizing AntibodiesIBA 01/2019
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2013
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2009
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2009
1	Messenger RNA (mRNA)IBA 01/2009
1	Everolimus FDA Link 02/2008
1	Peptides (Polypeptides)IBA 02/2008

3	Therapeutics 06/2021 - 01/2013
1	Lasers (Laser) 01/2009
1	Percutaneous Coronary Intervention 02/2008
1	Stents 04/2004